Nihon Kohden (NHNKY) Expected to Announce Quarterly Earnings on Tuesday

Nihon Kohden (OTCMKTS:NHNKY) is expected to be posting its resultson Tuesday, May 12th. Analysts expect Nihon Kohden to post earnings of $0.24 per share and revenue of $414.3960 million for the quarter.

Nihon Kohden (OTCMKTS:NHNKY) last released its quarterly earnings results on Thursday, February 5th. The company reported $0.16 earnings per share for the quarter. The business had revenue of $362.86 million for the quarter. Nihon Kohden had a net margin of 5.32% and a return on equity of 7.25%. On average, analysts expect Nihon Kohden to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Nihon Kohden Price Performance

OTCMKTS:NHNKY traded up $0.06 during trading hours on Tuesday, hitting $9.19. The company had a trading volume of 38,045 shares, compared to its average volume of 31,117. The company has a market capitalization of $1.57 billion, a PE ratio of 18.02 and a beta of 0.41. The stock has a 50-day moving average price of $9.76 and a 200 day moving average price of $10.70. Nihon Kohden has a 52 week low of $8.93 and a 52 week high of $14.21.

Analysts Set New Price Targets

A number of analysts have recently commented on NHNKY shares. UBS Group upgraded shares of Nihon Kohden from a “hold” rating to a “strong-buy” rating in a report on Monday, January 19th. Zacks Research upgraded shares of Nihon Kohden to a “hold” rating in a report on Monday, April 27th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Buy”.

Nihon Kohden Company Profile

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.